BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 34386813)

  • 21. Screening and identification of angiogenesis-related genes as potential novel prognostic biomarkers of hepatocellular carcinoma through bioinformatics analysis.
    Zhen Z; Shen Z; Hu Y; Sun P
    Aging (Albany NY); 2021 Jul; 13(13):17707-17733. PubMed ID: 34252885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Predictive Model Based on the FBXO Family Reveals the Significance of Cyclin F in Hepatocellular Carcinoma.
    Gao D; Li S; Guo H; Liu X; Liu Z; Li L; Bao L; Dang X
    Front Biosci (Landmark Ed); 2024 May; 29(5):202. PubMed ID: 38812312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multi-omics data identified TP53 and LRP1B as key regulatory gene related to immune phenotypes via EPCAM in HCC.
    Shi L; Cao J; Lei X; Shi Y; Wu L
    Cancer Med; 2022 May; 11(10):2145-2158. PubMed ID: 35150083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma.
    Wang Z; Zhu J; Liu Y; Liu C; Wang W; Chen F; Ma L
    J Transl Med; 2020 Feb; 18(1):67. PubMed ID: 32046766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel prognostic index of hepatocellular carcinoma based on immunogenomic landscape analysis.
    Xiao H; Wang B; Xiong HX; Guan JF; Wang J; Tan T; Lin K; Zou SB; Hu ZG; Wang K
    J Cell Physiol; 2021 Apr; 236(4):2572-2591. PubMed ID: 32853412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor-adjacent tissue co-expression profile analysis reveals pro-oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinoma.
    Grinchuk OV; Yenamandra SP; Iyer R; Singh M; Lee HK; Lim KH; Chow PK; Kuznetsov VA
    Mol Oncol; 2018 Jan; 12(1):89-113. PubMed ID: 29117471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune-related microRNA signature for predicting prognosis and the immune microenvironment in hepatocellular carcinoma.
    Li Y; He X; Zhang X; Xu Y; Wu Y; Xu X
    Life Sci; 2021 Jan; 265():118799. PubMed ID: 33220285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A signature of 33 immune-related gene pairs predicts clinical outcome in hepatocellular carcinoma.
    Sun XY; Yu SZ; Zhang HP; Li J; Guo WZ; Zhang SJ
    Cancer Med; 2020 Apr; 9(8):2868-2878. PubMed ID: 32068352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and validation of EPHX2 as a prognostic biomarker in hepatocellular carcinoma.
    Zhan K; Bai Y; Liao S; Chen H; Kuang L; Luo Q; Lv L; Qiu L; Mei Z
    Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploring the Prognostic Value, Immune Implication and Biological Function of
    Huang Y; Huang S; Ma L; Wang Y; Wang X; Xiao L; Qin W; Li L; Yuan X
    Front Immunol; 2021; 12():723293. PubMed ID: 34899687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cell death-related genes machine learning model for precise therapy and clinical drug selection in hepatocellular carcinoma.
    Du M; Qu Y; Qin L; Zheng J; Sun W
    J Cell Mol Med; 2024 Apr; 28(7):e18168. PubMed ID: 38494848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and validation of a CTNNB1-associated metabolic prognostic model for hepatocellular carcinoma.
    Huo J; Wu L; Zang Y
    J Cell Mol Med; 2021 Jan; 25(2):1151-1165. PubMed ID: 33300278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a thirteen-gene signature predicting overall survival for hepatocellular carcinoma.
    Zhou X; Liu C; Zeng H; Wu D; Liu L
    Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33835133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LRP1B is a Potential Biomarker for Tumor Immunogenicity and Prognosis of HCC Patients Receiving ICI Treatment.
    Cheng Y; Tang R; Li X; Wang B; Cheng Y; Xiao S; Sun P; Yu W; Li C; Lin X; Zhu Y
    J Hepatocell Carcinoma; 2022; 9():203-220. PubMed ID: 35345553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of prognostic markers for hepatocellular carcinoma based on the epithelial-mesenchymal transition-related gene BIRC5.
    Xu R; Lin L; Zhang B; Wang J; Zhao F; Liu X; Li Y; Li Y
    BMC Cancer; 2021 Jun; 21(1):687. PubMed ID: 34112092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pan-cancer analysis of LRRC59 with a focus on prognostic and immunological roles in hepatocellular carcinoma.
    Pan B; Cheng J; Tan W; Wu X; Fan Q; Fan L; Jiang M; Yu R; Cheng X; Deng Y
    Aging (Albany NY); 2024 May; 16(9):8171-8197. PubMed ID: 38738999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. KIF18B as a regulator in tumor microenvironment accelerates tumor progression and triggers poor outcome in hepatocellular carcinoma.
    Qiu MJ; Zhang L; Chen YB; Zhu LS; Zhang B; Li QT; Yang SL; Xiong ZF
    Int J Biochem Cell Biol; 2021 Aug; 137():106037. PubMed ID: 34217812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of immune-related lncRNA signature for predicting immune checkpoint blockade and prognosis in hepatocellular carcinoma.
    Xu Q; Wang Y; Huang W
    Int Immunopharmacol; 2021 Mar; 92():107333. PubMed ID: 33486322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Construction of the panoptosis-related gene model and characterization of tumor microenvironment infiltration in hepatocellular carcinoma.
    Shi X; Gao X; Liu W; Tang X; Liu J; Pan D; Duan X; Jin Y; Ren W; Yang L; Liu W
    Oncol Res; 2023; 31(4):569-590. PubMed ID: 37415742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.